Oral cancers are among the common head and neck malignancies. Different anticancer
therapy modalities such as chemotherapy, immunotherapy, radiation therapy, and also …

A concise review covering updated presence and role of 2-phenethylamines in medicinal
chemistry is presented. Open-chain, flexible alicyclic amine derivatives of this motif are …

Preclinical animal models of oral squamous cell carcinoma (OSCC) have been extensively
studied in recent years. Investigating the pathogenesis and potential therapeutic strategies …

Simple Summary Oral cavity is the most common site of head and neck cancer which is
ranked as the eighth most common cancer worldwide. Oral cancer treatment is often …

Oral leukoplakia (OLK) has gained extensive attention because of the potential risk for
malignant transformation. Photosensitizers (PSs) played an indispensable role in the …

The immune checkpoint inhibitor (ICI), anti–programmed death-1 (anti–PD-1), has shown
moderate efficacy in some patients with head and neck squamous cell carcinoma (HNSCC) …

Oral squamous cell carcinoma (OSCC) is the most common subsite of head and neck
cancer, with a 5-year survival rate of only 50%. There is a pressing need for animal models …

Cell-based drug delivery system holds a great promise in anticancer treatment, due to its
potential of maximizing therapeutic efficacy while minimizing adverse effects. However …

Oral potentially malignant disorders (OPMDs) are linked with an escalated risk of develo**
cancers, particularly oral squamous cell carcinoma (OSCC). Since prevailing therapies …

The most prevalent oral cancer globally is oral squamous cell carcinoma (OSCC). The
invasion of adjacent bones and the metastasis to regional lymph nodes often lead to poor …